.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Argus Health
UBS
Johnson and Johnson
Citi
Cipla
Federal Trade Commission
Baxter
Covington
Fuji

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070947

« Back to Dashboard

NDA 070947 describes PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Actavis Elizabeth, Ani Pharms Inc, Ivax Sub Teva Pharms, Mylan, Sandoz, Warner Chilcott, and Watson Labs, and is included in seventeen NDAs. It is available from one supplier. Additional details are available on the PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE profile page.

The generic ingredient in PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.

Summary for 070947

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 070947

Ingredient-typeThiazides
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 070947

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070947 ANDA Mylan Pharmaceuticals Inc. 0378-0347 0378-0347-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0347-01)
PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070947 ANDA Mylan Pharmaceuticals Inc. 0378-0731 0378-0731-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0731-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;80MG
Approval Date:Apr 1, 1987TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;40MG
Approval Date:Mar 4, 1987TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Express Scripts
Dow
Teva
AstraZeneca
Cantor Fitzgerald
Fuji
Fish and Richardson
Queensland Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot